Low rate of cancer detection by colonoscopy in asymptomatic, average-risk subjects with negative results from fecal immunochemical tests

GF Longstreth, DS Anderson, DS Zisook, JM Shi… - Clinical …, 2020 - Elsevier
Background & Aims Screening colonoscopies are of uncertain benefit for persons with
negative results from a fecal immunochemical test (FIT). We investigated detection of CRC …

Risk factors for metachronous colorectal cancer in Lynch syndrome patients: a registry-based observational mono-institutional study cohort

S Signoroni, GN Piozzi, MT Ricci, A Mancini… - International Journal of …, 2020 - Springer
Background Risk factors for metachronous colorectal cancer (mCRC) in Lynch Syndrome
(LS) patients are essential for colorectal cancer (CRC) treatment strategy to perform not only …

[HTML][HTML] Colorectal cancer screening outcomes of 2412 prostate cancer patients considered for carbon ion radiotherapy

N Kobayashi, T Oike, N Kubo, Y Miyasaka, T Mizukami… - Cancers, 2021 - mdpi.com
Simple Summary Colorectal cancer (CRC) screening is effective for cancer detection in
average-risk adults. For prostate cancer (PCa) patients considered for carbon ion …

Update on flexible sigmoidoscopy, computed tomographic colonography, and capsule colonoscopy

SW Chung, S Hakim, S Siddiqui… - Gastrointestinal …, 2020 - giendo.theclinics.com
In the context of colorectal cancer (CRC) screening and surveillance, colonoscopy is
considered the gold-standard test, and the increasing availability and use of colonoscopy …

[HTML][HTML] Cancer Risk C (CR-C), a functional genomics test is a sensitive and rapid test for germline mismatch repair deficiency

I Alim, J Loke, S Yam, AS Templeton, P Newcomb… - Genetics in …, 2022 - Elsevier
Purpose Heritable pathogenic variants in the DNA mismatch repair (MMR) pathway cause
Lynch syndrome, a condition that significantly increases risk of colorectal and other cancers …

[HTML][HTML] Utility of circulating tumor cells in stage II colorectal cancer patients undergoing curative resection

JH Yu, D Wang, L Jin, J Wang, XM Zhao… - Translational Cancer …, 2020 - ncbi.nlm.nih.gov
Background The aim of this study was to determine whether circulating tumor cells (CTCs)
have utility as a prognostic biomarker in stage II colorectal cancer (CRC), as well as a …

[HTML][HTML] Subtypes of minimal residual disease and outcome for stage II colon cancer treated by surgery alone

NP Murray, S Aedo, R Villalon, V Albarran… - …, 2020 - ncbi.nlm.nih.gov
Results One hundred and eighty-one patients (82 men) have participated, mean age was 68
years and median follow-up was 4.04 years (A (N= 105), B (N= 36) and C (N= 40)). For the …

[HTML][HTML] Intervenciones en ámbito laboral para incrementar el rastreo de cáncer colorrectal: evaluación de tecnología sanitaria

L González, AP Riviere, J Roberti… - Revista Argentina de …, 2021 - SciELO Argentina
MÉTODOS: Se realizó una búsqueda en bases de datos bibliográficas, buscadores
genéricos de Internet y sitios ministeriales de salud y educación nacionales. RESULTADOS …

MSI 在结直肠癌中的应用研究新进展.

杨镜玉, 李文亮 - Journal of Kunming Medical University …, 2020 - search.ebscohost.com
微卫星不稳定性(microsatellite instability, MSI) 是由DNA 错配修复(mismatchrepair, MMR)
蛋白功能缺失所导致, 其分子特征被认为是重要的基因标记物, 在结直肠癌的筛查, 分类, 诊断 …

Colorectal Cancer Screening Guidelines Are Primarily Based on Low–Moderate-Quality Evidence

S Weissman, A Goldowsky, M Aziz, TI Mehta… - Digestive Diseases and …, 2021 - Springer
Background Owning to colorectal cancer's (CRC) high mortality, multiple societies
developed screening guidelines. Aims We aimed to assess the overall quality of CRC …